Skip to main content
Equibles

UBS Group AG

Position in TCRT — Alaunos Therapeutics, Inc.

CIK 1610520 ZURICH, V8
Back to TCRT Full portfolio

Position in TCRT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$2,240
-$4,262 QoQ
Shares Held
992
-56.4% QoQ
Ownership
0.039%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 29 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 95% Shared 0% None 5%

Common Shares in TCRT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,801 across 560 Biotechnology names. TCRT ranks #498 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in TCRT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,240 992
2026-03-31 $6,502 2,274
2025-12-31 $4,226 1,309
2025-09-30 $3,693 1,533
2025-06-30 $33,051 6,815
2025-03-31 $11,566 7,869
2024-12-31 $15,029 7,869
2024-09-30 $3,309 1,028
2024-06-30 $38,393 54,849
2024-03-31 $29,302 16,190
2023-12-31 $10,794 154,206
2023-09-30 $34,021 261,712
2023-06-30 $127,389 249,784
2023-03-31 $157,970 250,748
2022-12-31 $176,688 271,829
2022-09-30 $496,386 288,597
2022-06-30 $332,537 268,175
2022-03-31 $217,583 334,744
2021-12-31 $1,105,756 1,014,456
2021-09-30 $1,333,030 732,435
2021-06-30 $937,469 355,102
2021-03-31 $2,580,281 716,745
2020-12-31 $1,022,114 405,601
2020-09-30 $1,122,989 445,631
2020-06-30 $1,817,329 554,064
2020-03-31 $1,584,838 646,873